Share This:

Abstract for TR-144 - 2-Aminoanthraquinone (CASRN 117-79-3)


Bioassay of 2-Aminoanthraquinone for Possible Carcinogenicity (CAS No. 117-79-3)

Link to the full study report in PDF. If you have difficulty accessing the document, please send email to the NTP Webmaster [ Send Email ] and identify documents/pages for which access is required. 


Chemical Formula:  C14H9NO2

2-Aminoanthraquinone, an intermediate in the synthesis of anthraquinone dyes, was selected for bioassay by the National Cancer Institute in an attempt to determine which chemicals may be responsible for the increased incidence of bladder cancer observed among workers in the dye manufacturing industry. Aromatic amines are one of several classes of chemicals thought to contribute to the increased cancer risk in this industry.

A bioassay of 2-aminoanthraquinone for possible carcinogenicity was conducted using Fischer 344 rats and B6C3F1 mice. 2-Aminoanthraquinone was administered in the feed, at either of two concentrations (except for female rats), to groups of 50 male and 50 female animals of each species. The time-weighted average dietary concentrations used in the chronic bioassay were 0.69 and 0.35 percent for high and low dose male rats, respectively, 0.2 percent for the treated female rats, and 1.0 and 0.5 percent, respectively, for high and low dose mice of both sexes. After a 78-week period of chemical administration (80 weeks for high dose mice), observation of the rats continued for up to an additional 32, weeks and observation of the mice continued for up to an additional 16 weeks.

In both species adequate numbers of animals in all groups, except the treated female rats, survived sufficiently long to be at risk from late-developing tumors. The survival among treated female rats was poor and, as a result, no conclusions could be made regarding the carcinogenicity of the compound in these animals.

When male rats having either hepatocellular carcinomas or neoplastic nodules of the liver were combined and the resulting tumor incidences were analyzed statistically, there was a significant positive association between dosage and the incidences of these combined neoplasms. Hepatocellular carcinomas were observed at significantly higher incidences when dosed mice were compared to controls. There was a significantly higher incidence of malignant hematopoietic lymphomas in high dose female mice when compared to controls.

Under the conditions of this bioassay, dietary administration of 2-aminoanthraquinone was carcinogenic in male Fischer 344 rats, causing a combination of hepatocellular carcinomas and neoplastic nodules of the liver. The compound was also carcinogenic in B6C3F1 mice, causing hepatocellular carcinomas in both sexes and malignant hematopoietic lymphomas in females.


Levels of Evidence of Carcinogenicity:
Sex Species Results
Male Rats: Positive
Female Rats: Inadequate Study
Male Mice: Positive
Female Mice: Positive

Synonyms: 2-amino-9,10-anthracenedione; AAQ

Report Date: 1978

Target Organs from 2-year Studies

Return to Long Term Abstracts